*AdvaCare Artesunate + Amodiaquine Tablets are GMP certified.
**AdvaCare Artesunate + Amodiaquine Tablets are manufactured in our facilities located in China/India/USA.
200mg + 600mg
3+3 tablets/blister, 1 blister/box
Artesunate, Amodiaquine
Artesunate, Amodiaquine
Product Information
General Information:
AdvaCare is a GMP manufacturer of Artesunate and Amodiaquine Tablets
Artesunate + Amodiaquine is a potential combination manufactured for inhibiting intensification of drug resistance and for malaria treatment. Artesunate and amodiaquine tablets are an antimalarial agent. Artesunate is ideal for the treatment of uncomplicated cases of malaria due to Plasmodium falciparum malaria, including cerebral malaria, and amodiaquine is a 4-aminoquinoline compound related to chloroquine used as an antimalarial and anti-inflammatory agent.
Side Effects:
As with all pharmaceuticals, some unwanted effects can occur from the use of artesunate + amodiaquine tablets. Always consult a doctor or health care professional for medical advice before use. Common side effects include, but may not be limited to diarrhea, skin rash, itching, and nausea. Seek medical attention if the following develop: irregular heart beating, diplopia, dizziness.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.
-
For more information about our Artesunate + Amodiaquine Tablets
email us at: info@advacarepharma.com
Additional Information
Always consult your doctor or pharmacist before taking artesunate and amodiaquine.
If your condition does not improve or becomes worse, then call your doctor.
Driving or operating machinery should be avoided, as it does may cause dizziness.
Do NOT use artesunate + amodiaquine tablets if:
- You are hypersensitive to the active substances or to any ingredients within the drug.
- You have a history of liver injury during treatment with amodiaquine.
- You have had a previous hematological event during treatment with amodiaquine.
Use of artesunate + amodiaquine tablets during pregnancy or breastfeeding has not indicated any problems for a fetus and/or baby. Consult your doctor or health care professional before taking the medicine.
Refer to your doctor or pharmacist for guidelines on dosage. Do not exceed what they advise. The recommended dosage is 10 mg/kg base once daily for 3 days
Interactions with drugs used for the treatment of HIV and/or tuberculosis may occur, and as well as this there are several other known interactions with this drug. Consult with your doctor about any medications you are taking, before your treatment with artesunate and amodiaquine tablets.
Interested in more Products?
For more antimalarial tablets, you can also check the following related products: